510(k) device
Barrigel Injectable Gel
Palette Life Sciences · Hydrogel Spacer (OVB, Class II) · First FDA decision May 26, 2022, newest May 26, 2022Cancer radiation therapyProstate cancer
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
2
Naming "Barrigel Injectable Gel"
MAUDE reports
26
Brand "Barrigel Injectable Gel", since 2015
PubMed studies
0
Mentioning "Barrigel Injectable Gel"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Barrigel Injectable Gel
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Barrigel Injectable Gel510(k)
K220641 · Decided May 26, 2022 · 83 days after receipt
Device type: Hydrogel Spacer (OVB) · Radiology & Imaging
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Barrigel Injectable Gel", any status and sponsor, newest update first.
Palette Life Sciences, Inc.Not on our public-company list
NCT06496256 · 84 participants (planned) · Start Oct 31, 2024 · Primary completion Dec 1, 2028
Device: Barrigel; Transrectal Ultrasound · For: Prostate Cancer
Sites: Chandler, Arizona; Santa Barbara, California; Boca Raton, Florida · 13 sites in all
NYU Langone HealthAcademic, hospital or other
NCT07567027 · 20 participants (planned) · Start Jun 17, 2026 · Primary completion Dec 1, 2027
Device: Barrigel Injectable Gel · For: Prostate Cancer (Diagnosis); Transperineal Cryoablation
Sites: New York, New York
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Barrigel Injectable Gel", and for the whole product code for context.
This brand
26 reports: 5 malfunction, 19 injury, 2 death
Whole product code OVB
2,186 reports: 1,382 malfunction, 794 injury, 10 death
Newest reports for this brand
- BARRIGEL INJECTABLE GELInjury
3014909464-2025-00059 · Received Oct 21, 2025 · Event dated Sep 29, 2025
Device type: Hydrogel Spacer (OVB)
Device problem as coded: Malposition of Device
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- BARRIGEL INJECTABLE GELMalfunction
3014909464-2025-00053 · Received Oct 20, 2025 · Event dated Sep 19, 2025
Device type: Hydrogel Spacer (OVB)
Device problem as coded: Appropriate Device Problem Term/Code Not Available
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- BARRIGEL INJECTABLE GELInjury
3014909464-2025-00047 · Received Sep 29, 2025 · Event dated Sep 2, 2025
Device type: Hydrogel Spacer (OVB)
Device problem as coded: Malposition of Device
Patient problem as coded: Insufficient Information
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Barrigel Injectable Gel"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code OVB.
- SpaceOAR SystemAugmenix, Inc. · De Novo 2018
- SpaceOAR Flex SystemBoston Scientific Corporation · 510(k) 2026
- SpaceOAR Vue System (SV-2101)Boston Scientific Corporation · 510(k) 2026
- BioProtect Balloon Implant SystemBioprotect, Ltd. · 510(k) 2023
- SpaceOAR SystemBoston Scientific Corporation · 510(k) 2020
- SpaceOAR Vue HydrogelAugmenix, Inc. · 510(k) 2019
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.